News
The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...
When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.
Adolescents with cancer and their parents said parents should have access to non-sensitive information in patient portals.
HHS Secretary Robert F. Kennedy Jr. abruptly postponed a meeting of the USPSTF, raising concerns that he will be reshaping the task force.
The FDA has accepted the supplemental new drug application for decitabine/cedazuridine plus venetoclax to treat adults with AML.
Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.
The FDA has published more than 200 complete response letters, sent as replies for applications submitted from 2020 to 2024.
Childhood cancer survivors have a higher risk of developing severe COVID-19 than the general population, data suggest.
We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited cont ...
Mass firings and grant terminations have disrupted research and other operations at the National Cancer Institute.
The addition of metformin “was generally well tolerated but did not result in the targeted benefit of a 20% reduction in risk of death in an unselected population,” the researchers wrote.
Olaparib demonstrated activity in a phase 2 trial of patients who had advanced biliary tract cancer with homologous recombination repair (HRR) mutations. Results from this trial were presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results